Journal Logo

Letters

Reply: Use of Hyaluronic Acid Fillers for Acquired Contour Deformities

Hudson, Don A. F.R.C.S., F.C.S.(S.A.), M.Med.

Author Information
Plastic and Reconstructive Surgery: April 2019 - Volume 143 - Issue 4 - p 890e-891e
doi: 10.1097/PRS.0000000000005460
  • Free

Sir:

I thank Dr. Cuomo et al. for reading my Viewpoint article1 and for their useful comments. It seems that they have encountered similar clinical problems and investigated different solutions. I will respond as follows.

First, I agree that botulinum toxin can and should also be used with fillers where appropriate—and this was used in the patient with facial nerve dysfunction secondary to incomplete recovery after Bell palsy.

Second, I disagree with Cuomo et al. regarding longevity of hyaluronic acid fillers. It is well beyond 12 months for many fillers,2 especially when inserted where there is no or little tissue movement.

Third, although “permanent” fillers are attractive, the fact that there are many on the market suggests that there is no “ideal” permanent filler. Also, should a local complication3,4 occur, the problem is “permanent”—and may require an operative solution, thus explaining the attraction of hyaluronic acid fillers, which can be dissolved. Hydroxyapatite fillers are not available in my country.

Fourth, as a plastic surgeon, I love lipofilling and look forward to further advancements to reduce the rate of fat resorption. Their idea of mixing fat grafts combined with growth factors and the stromal vascular fraction is not new. There are suggestions that the latter improves fat survival,5 but resorption is still a problem.

Fifth, it appears that they have tried mixing hyaluronic acid fillers with the stromal vascular fraction emulsion, which is a novel concept, and I look forward to a large series with long-term results.

Sixth, there is a new concept in fillers—myomodulation—as advocated by de Maio6 that may be particularly useful in facial asymmetry, whether congenital or acquired. The concept presented is that fillers can be used to modulate muscle action and restore balance between agonists and antagonists. Fillers can be used to support weak muscle by injecting hyaluronic acid under the muscle, which enhances the fulcrum action of the muscle. Similarly, an overactive muscle can have its action reduced, by injecting hyaluronic acid superficial to the muscle. I think we will see more application of this in the future.

Plastic surgery is a technique-driven specialty that may require innovative solutions to difficult or uncommon clinical problems. This is part of the attraction of a wonderful profession.

DISCLOSURE

The author has no financial interest to declare in relation to the content of this communication. No funding was received for this communication.

Don A. Hudson, F.R.C.S., F.C.S.(S.A.), M.Med.
University of Cape Town
Cape Town, South Africa

REFERENCES

1. Hudson DA. Use of hyaluronic acid fillers for acquired contour deformities. Plast Reconstr Surg. 2018;142:244e–245e.
2. Hermann JL, Hoffmann RK, Ward CE, Schulman JM, Grekin RC. Biochemistry, physiology and tissue interactions of contemporary biodegradable injectable dermal fillers. Dermatol Surg. 2018;44(Suppl 1):S19–S31.
3. Ozturk CN, Yumeng L, Tung R, Parker L, Piliang MP, Zins JE. Complications following injection of soft-tissue fillers. Aesthet Surg J. 2013;33:862–877.
4. Cassuto D, Pignatti M, Pacchini L. Management of complications caused by permanent fillers in the face: A treatment algorithm. Plast Reconstr Surg. 2016:138:215–227.
5. Wei C, Li-dong Y, Xioawei T, Gan S. The stromal vascular fraction improves maintenance of the fat graft volume. Ann Plast Surg. 2018;81:367–371.
6. de Maio M. Myomodulation with injectable fillers: An innovative approach to addressing facial muscle movement. Aesthetic Plast Surg. 2018;42:798–814.

GUIDELINES

Letters to the Editor, discussing material recently published in the Journal, are welcome. They will have the best chance of acceptance if they are received within 8 weeks of an article’s publication. Letters to the Editor may be published with a response from the authors of the article being discussed. Discussions beyond the initial letter and response will not be published. Letters submitted pertaining to published Discussions of articles will not be printed. Letters to the Editor are not usually peer reviewed, but the Journal may invite replies from the authors of the original publication. All Letters are published at the discretion of the Editor.

Letters submitted should pose a specific question that clarifies a point that either was not made in the article or was unclear, and therefore a response from the corresponding author of the article is requested.

Authors will be listed in the order in which they appear in the submission. Letters should be submitted electronically via PRS’ enkwell, at www.editorialmanager.com/prs/.

We reserve the right to edit Letters to meet requirements of space and format. Any financial interests relevant to the content of the correspondence must be disclosed. Submission of a Letter constitutes permission for the American Society of Plastic Surgeons and its licensees and asignees to publish it in the Journal and in any other form or medium.

The views, opinions, and conclusions expressed in the Letters to the Editor represent the personal opinions of the individual writers and not those of the publisher, the Editorial Board, or the sponsors of the Journal. Any stated views, opinions, and conclusions do not reflect the policy of any of the sponsoring organizations or of the institutions with which the writer is affiliated, and the publisher, the Editorial Board, and the sponsoring organizations assume no responsibility for the content of such correspondence.

The Journal requests that individuals submit no more than five (5) letters to Plastic and Reconstructive Surgery in a calendar year.

Copyright © 2019 by the American Society of Plastic Surgeons